Advertisement

Topics

Companies Related to "Biomarkers in Patients With Rectal Cancer Undergoing Chemotherapy and Radiation Therapy" [Most Relevant Company Matches] RSS

06:09 EST 20th February 2019 | BioPortfolio

Here are the most relevant search results for "Biomarkers in Patients With Rectal Cancer Undergoing Chemotherapy and Radiation Therapy" found in our extensive corporate database of over 50,000 company records.

Showing "Biomarkers Patients With Rectal Cancer Undergoing Chemotherapy Radiation" Companies 1–25 of 5,800+

Extremely Relevant

OncoWell, LLC

OncoWell, LLC, headquartered in New York, NY, provides complementary products and resources to patients undergoing cancer treatment. The company’s first offering, OncoWellCE, is a concentrated enzyme product to support patient wellness while undergoing chemotherapy or radiation therapy. OncoWell, LLC was founded in 2012 by James Nicholls, Peter Jenkin...


Kepivance™ (palifermin)

Kepivance™ (palifermin) is indicated to decrease the incidence and duration of severe oral mucositis (mouth sores) in patients withhematologic (blood) cancers undergoing high-dose chemotherapy, with or without radiation, followed by bone marrow transplant. The safety and efficacy of Kepivance™ have not been established in patients with nonhematologic malignancies.

Relevant

Cancer Therapeutics, Inc.TM

Founded in 1991, Cancer Therapeutics, Inc.TM (CTI) is a biotherapy company that is a leader in activated cell technology for cancer therapy. CTI's laboratory offers access to technologies grouped under the modality of Biotherapy. Biotherapy is based on treatments that enhance the patient's own immune system to attack the invading cancer. Research has shown cancer to be a highly individualized dise...


Medifocus Inc.

Medifocus owns a patented microwave focusing technology platform the Adaptive Phased Array ("APA") system, which can precisely target and concentrate microwave energy to destroy cancer tumors without damaging healthy tissue when used alone or in conjunction with chemotherapy or radiation. The ability to target tumors with a precision controlled dose of hea...

Medifocus, Inc.

Medifocus owns a patented microwave focusing technology platform the Adaptive Phased Array ("APA") system, which can precisely target and concentrate microwave energy to destroy cancer tumors without damaging healthy tissue when used alone or in conjunction with chemotherapy or radiation. The ability to target tumors with a precision controlled dose of hea...

Cancer Supportive Care Programs

The mission of the Cancer Supportive Care Web Site (CSCW) is to provide multidisciplinary information and services for cancer patients and their families/friends This website provides online support for patients undergoing surgery, radiation therapy, chemotherapy, hormonal therapy or immunotherapy. El Cuidado Sustento Del Cáncer de Ernest H. Rosenbaum, MD y Isadora R. Rosenbaum, MA La Declaració...

Targeted Diagnostics and Therapeutics

TDT has emerged as a leader in the development of innovative molecular diagnostics and therapeutics that can improve the quality of life of patients with colorectal cancer and gastrointestinal malignancies. Focused on innovative research and cutting edge technology, TDT has developed highly specific tests to detect colorectal cancer cells in lymph nodes from patients who have undergone surgical st...

Sonrgy, Inc.

Sonrgy is a preclinical stage biotechnology company based in San Diego, California that is developing a targeted chemotherapy delivery platform to improve survival and quality of life for millions of cancer patients. Sonrgy’s tiny nanocarriers safely transport potent chemotherapy drugs to cancer tumors and release high doses on command in response to a focus...

ProCertus BioPharm, Inc.

ProCertus BioPharm is an oncology-based pharmaceutical company whose primary mission is to protect cancer patients against the side effects of chemotherapy and radiotherapy.ProCertus has established proof of concept in animal models for its product candidates, DermX, ProDermaCel™, and OralX, proprietary pharmaceuticals designed to reduce or eliminate the side effects associated with cancer thera...

Arizona Oncology Services

Arizona Oncology Services (AOS) provides Radiation Oncology Services at fourteen facilities in the greater Phoenix region and Yuma, which are listed below. Of these facilities eight are owned and operated by AOS, four are Radiation Oncology Departments within hospitals to include St. Joseph's Hospital & Medical Center; Banner Desert Medical Center; Banner Good Samaritan Medical Center; and Banner ...

NeoRX Corporation

NeoRx Corporation develops innovative therapeutic biopharmaceuticals primarily for the treatment of cancer, cardiovascular, and inflammatory diseases. As part of its cancer treatment program, NeoRx is currently conducting a Phase I trial of its Skeletal Targeted Radiation ("STR") product combined with chemotherapy in patients with multiple myeloma. NeoRx is also developing a proprietary PRETARGET-...

Xoft Inc.

Xoft, founded in 1998, develops Electronic Brachytherapy (eBx) systems based upon miniaturized X-ray tube technology for the practice of radiation oncology in virtually any clinical setting, eliminating the need for heavily shielded environments. Xoft provides a "point of care model" that is patient centric and accessible to a broader spectrum of patients and their physicians. The Axxent treat...

OvaGene Oncology Inc.

OvaGene Oncology is a molecular diagnostics company, located in Orange County, California, dedicated to improving cancer care and outcomes for gynecologic cancer patients through the development of novel gene-based assays. The company plans to offer proprietary and non-proprietary molecular diagnostic assays to assist physicians in the prognosis of gynecologic cancers as well as therapy selection...

OnCure Holdings, Inc.

OnCure Holdings, Inc. operates radiation oncology treatment centers for cancer patients. Oncure Medical Corp. (“Oncure”), a wholly-owned subsidiary of OnCure Holdings, Inc., contracts with radiation oncology medical groups and their radiation oncologists through long-term management services agreements to offer cancer patients a comprehensive ran...

DiaTech Oncology

DiaTech Oncology is a privately held clinical pathology laboratory that offers patient-specific chemotherapy testing to help oncologists determine the best cancer treatment plans for their patients. DiaTech utilizes a patented technology called the Microculture Kinetic (MiCK) assay, which measures apoptosis (cell death) induced in a specific patient’s...

America Stem Cell, Inc.

America Stem Cell is a privately held biotechnology company based in San Antonio, TX, with offices in San Diego, CA, and is dedicated to the development and commercialization of stem cell enabling technologies/products to transform clinical outcomes for patients undergoing stem cell transplantation. The key stem cell enabling platform technologies/compound...

Oncology Hematology Group of South Florida

We truly care about our patients. Our compassionate doctors rely on the latest treatments and advanced technologies-many of which are available at OHGSF long before other medical practices. Constantly seeking ways to improve results, our physicians always put the patient first anr never sacrifice quality of care. We handle every aspect of a patient's treatment from chemotherapy and radiation to th...

US Oncology Network

Optim Oncology is dedicated to providing patient-centered, integrated cancer care in convenient locations close to patients’ homes. Medical and radiation specialists work together in one location to facilitate fully coordinated comprehensive team care, providing the potential for better outcomes and reducing patients’ stress by eliminating the need to ...

Millennium Biotechnologies, Inc.

Millennium's six marketed products form its advanced line of nutritional formulas. Resurgex Select(R) is a whole foods-based, calorically dense, high-protein nutritional formula developed for cancer patients undergoing chemotherapy or radiation treatments. Resurgex(R) and Resurgex Plus(R) are specialized, anabolic nutritional supplements rich in antioxidants that provide nutritional support po...

Targeted Diagnostics & Therapeutics, Inc

TDT has emerged as a leader in the development of innovative molecular diagnostics and therapeutics that can improve the quality of life of patients with colorectal cancer and gastrointestinal malignancies. Focused on innovative research and cutting edge technology, TDT has developed highly specific tests to detect colorectal cancer cells in lymph nodes from patients who have undergone surgical st...

Alliance Oncology

Alliance Oncology partners with hospitals and radiation oncologists to set a new standard of care for cancer patients. This is achieved through the establishment of state-of-the-art cancer centers or the enhancement of existing facilities with advanced technologies, including Intensity Modulated Radiation Therapy (IMRT), Image Guided Radiation Therapy (IGR...

CTCA

CTCA is the home of integrative and compassionate cancer care.We never stop searching for and providing powerful and innovative therapies to heal the whole person, improve quality of life and restore hope. In short, Cancer Treatment Centers of America (CTCA) is committed to helping people overcome cancer. The best way we know how is by listening to our patients. By empowering and encouraging each ...

Ortho Biotech

In 1990, Ortho Biotech was established as the first biotechnology subsidiary of Johnson & Johnson.Today, our products and treatments combat some of the most serious diseases - such as cancer, HIV/AIDS, and chronic kidney disease. They also help restore the health and comfort of patients undergoing elective surgery, organ transplants, and chemotherapy.We are a leader in the worldwide treatment of a...

Novacea

We are a biopharmaceutical company focused on in-licensing, developing and commercializing novel therapies for the treatment of cancer. We currently have two clinical-stage oncology product candidates. Our lead product candidate, Asentar™ (DN-101), is in a Phase 3 clinical trial for the treatment of androgen-independent prostate cancer, or AIPC, also known as hormone-refractory prostate cancer. ...

Radiation Therapy Services, Inc.

Radiation Therapy Services, Inc. is a leading developer and operator of radiation therapy centers. These centers, which are freestanding and hospital based, provide a full spectrum of radiation therapy services to cancer patients, including conventional external beam radiation treatments as well as advanced services such as prostate seed implants (brachyth...


More From BioPortfolio on "Biomarkers in Patients With Rectal Cancer Undergoing Chemotherapy and Radiation Therapy"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks